Proteomics of Bordetella pertussis whole-cell and acellular vaccines

被引：6
|
作者：
Moeller, Jens [1 ]
Kraner, Max Edmund [2 ]
Burkovski, Andreas [1 ]
机构：
[1] Friedrich Alexander Univ Erlangen Nurnberg, Staudtstr 5, D-91058 Erlangen, Germany
[2] Friedrich Alexander Univ Erlangen Nurnberg, Lehrstuhl Biochem, Erlangen, Germany
来源：
BMC RESEARCH NOTES | 2019年 / 12卷 / 1期
关键词：
Bordetella; DTP vaccine; LC-MS; MS; Mass spectrometry; Pertussis; Vaccination; Whooping cough;
D O I：
10.1186/s13104-019-4373-2
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
ObjectivesBordetella pertussis is the etiological agent of whooping cough, a bacterial infection of especially children, which may be fatal without treatment. In frame of studies to investigate putative effects of vaccination on host-pathogen interaction and clonal distribution of strains, in addition to Corynebacterium diphtheriae and Clostridium tetani toxoid vaccines, also whole-cell and acellular pertussis vaccines were analyzed by mass spectrometry.Data descriptionLC-MS/MS spectra were generated and analyzed using B. pertussis genome data and proteins present in whole-cell and acellular pertussis vaccines were identified. Subcellular localization of proteins and presence of signal peptides was determined bioinformatically.
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Time to switch from whole cell to acellular pertussis vaccines?
    Finn, A
    Bell, F
    BMJ-BRITISH MEDICAL JOURNAL, 2000, 320 (7238): : 875 - 875
  • [42] COMPARISON OF 3-COMPONENT ACELLULAR PERTUSSIS-VACCINE (DTAP) WITH WHOLE-CELL PERTUSSIS VACCINES (DTWP) AS A PRIMARY SERIES
    BERNSTEIN, H
    ROTHSTEIN, E
    PICHICHERO, M
    REISINGER, K
    BLATTER, M
    ARBETER, A
    BERNSTEIN, D
    SMITH, J
    LONG, S
    KRAUSE, D
    PEDIATRIC RESEARCH, 1994, 35 (04) : A174 - A174
  • [43] BORDETELLA-PERTUSSIS WHOLE CELL VACCINES - EFFICACY AND TOXICITY
    TROLLFORS, B
    ACTA PAEDIATRICA SCANDINAVICA, 1984, 73 (04): : 417 - 425
  • [44] Effect of injection site on reactogenicity and immunogenicity of acellular and whole-cell pertussis component diphtheria-tetanus-pertussis vaccines in infants
    Tapiainen, T
    Cherry, JD
    Heininger, U
    VACCINE, 2005, 23 (43) : 5106 - 5112
  • [45] Comparative safety and immunogenicity of an acellular versus whole-cell pertussis component of diphtheria-tetanus-pertussis vaccines in senegalese infants
    Simondon, F
    Yam, A
    Gagnepain, JY
    Wassilak, S
    Danve, B
    Cadoz, M
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1996, 15 (12) : 927 - 932
  • [46] Impact of acellular and whole cell pertussis vaccines on disease burden
    Edwards, K. M.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 21 : 61 - 62
  • [47] Whole-cell pertussis vaccine protects against Bordetella pertussis exacerbation of allergic asthma
    Ennis, DP
    Cassidy, JP
    Mahon, BP
    IMMUNOLOGY LETTERS, 2005, 97 (01) : 91 - 100
  • [48] THE SAFETY OF ACELLULAR PERTUSSIS-VACCINE VS WHOLE-CELL PERTUSSIS-VACCINE
    ROSENTHAL, SR
    HABER, P
    CHEN, RT
    PEDIATRIC RESEARCH, 1995, 37 (04) : A114 - A114
  • [49] Duration of protection against Bordetella pertussis infection elicited by whole-cell and acellular vaccine priming in Polish children and adolescents
    Paradowska-Stankiewicz, Iwona
    Rumik, Agnieszka
    Bogusz, Joanna
    Zbrzezniak, Jakub
    Rastawicki, Waldemar
    Smietanska, Karolina
    Vargas-Zambrano, Juan C.
    Macina, Denis
    VACCINE, 2021, 39 (41) : 6067 - 6073
  • [50] The safety of acellular pertussis vaccine vs whole-cell pertussis vaccine - A postmarketing assessment
    Rosenthal, S
    Chen, R
    Hadler, S
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 1996, 150 (05): : 457 - 460
12345